Global Radiofrequency Ablation Devices Market Analysis 2024, Forecast To 2033
8 Mar, 2024
The radiofrequency ablation devices market has experienced rapid expansion, reaching $4.27 billion in 2023 and projected to hit $4.84 billion in 2024, exhibiting a CAGR of 13.3%. This growth is attributed to factors such as increased clinical acceptance and rising demand due to chronic diseases. Predicted growth to $7.6 billion by 2028, with a CAGR of 11.9%, is fueled by factors including the aging population and the integration of telemedicine. Major trends in the forecast period include the development of portable ablation devices and enhanced safety features, along with advancements in cancer ablation techniques and the adoption of remote and robotic assistance.
Global Radiofrequency Ablation Devices Market Key Driver
The radiofrequency ablation devices market is growing due to the increasing prevalence of chronic diseases. With a significant rise projected in the number of individuals with chronic illnesses, there's a growing demand for devices to alleviate chronic pain and shrink tumors, as highlighted by data from the National Library of Medicine.
Get A Free Sample Of The Global Radiofrequency Ablation Devices Market ReportGlobal Radiofrequency Ablation Devices Market Segments
The radiofrequency ablation devices market covered in this report is segmented –
1) Product Type:Disposables Equipment, Reusables Equipment, Capital Equipment
2) Application:Oncology, Cardiology And Cardiac Rhythm Management, Gynecology, Pain Management, Other Applications
3) End-User:Hospitals, Ambulatory Surgical Centers, Other End Users
By Geography: The countries covered in the radiofrequency ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the radiofrequency ablation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiofrequency ablation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Radiofrequency Ablation Devices Industry Players
Johnson And Johnson Co; Abbott Laboratories; Medtronic PLC; Siemens Healthineers; Becton, Dickinson and Company; Koninklijke Philips NV; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Smith And Nephew PLC; Ethicon Inc.; Hologic Inc.; Arthrex Inc.; Halyard Health Inc.; BIOTRONIK SE and Co KG; Merit Medical Systems Inc.; Conmed Corporation; Avanos Medical Inc.; ArtiCure Inc.; AngioDynamics Inc.; Biosense Webster Inc.; Baylis Medical Company Inc.; Sutter Medizintechnik GmbH; OSYPKA AG; Inomed Medizintechnik GmbH; St. Jude Medical Inc.; Epimed International Inc.
Get The Full Global Radiofrequency Ablation Devices Market Report
Radiofrequency Ablation Devices Market Overview
Radiofrequency ablation devices are medical devices that generate heat from medium-frequency alternating currents to ablate or destroy abnormal tissue. It destroys cancerous tissue and manages chronic pain by interrupting pain impulses.